Advertisement

Immune pathogenesis of hepatitis B

  • C. Ferrari
  • Amalia Penna
  • A. Bertoletti
  • A. Cavalli
  • A. Valli
  • G. Missale
  • M. Pilli
  • S. Marchelli
  • T. Giuberti
  • F. Fiaccadori
Part of the Archives of Virology book series (ARCHIVES SUPPL, volume 4)

Summary

Available information about the immune pathogenesis of HBV infection in man is very limited. However, the present availability of recombinant sources of the different HBV antigens expressed in the appropriate forms to induce activation of either HLA class I or HLA class II-restricted T cells, provides the necessary tools to investigate directly the mechanisms of liver damage, the role of the different cellular components of the immune system in HBV clearance and the specific nature of the immune defects potentially responsible for the chronic evolution of HBV infection. In addition, improved knowledge of HBV biology suggests a dynamic interpretation of the HBV-immune system interactions, based on which viral mutations as well as direct interferences of HBV with specific immune functions are believed to play a relevant role with respect to the outcome of HBV infection.

Keywords

Woodchuck Hepatitis Virus Immune Pathogenesis Eddleston ALWF Nucleocapsid Antigen Hepadnavirus Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barnaba V, Franco A, Alberti A, Balsano C, Benvenuto R, Balsano F (1989) Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J Immunol 143: 2650–2655PubMedGoogle Scholar
  2. 2.
    Barnaba V, Franco A, Alberti A, Benvenuto R, Balsano F (1990) Selective killing of hepatitis B envelope antigen-specific B cells by class I restricted, exogenous antigen specific T lymphocytes. Nature 345: 250–253CrossRefGoogle Scholar
  3. 3.
    Beasley RP, Hwang LY, Stevens CE, Lin CC, Hsieh FJ, Wang KJ, Sun TS, Szmuness W (1983) Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state. Hepatology 3: 135–141PubMedCrossRefGoogle Scholar
  4. 4.
    Brunetto MR, Stemler M, Bonino F, Schödel F, Oliveri F, Rizzetto M, Verme G, Will H (1990) A new hepatitis B virus strain in patients with severe anti-HBe positive chronic hepatitis B. J Hepatol 10: 258–261PubMedCrossRefGoogle Scholar
  5. 5.
    Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Markis A, Thomas HC (1989) Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet ii: 588–591CrossRefGoogle Scholar
  6. 6.
    Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC (1990) Vaccine-induced mutant of hepatitis B virus. Lancet ii: 325–329CrossRefGoogle Scholar
  7. 7.
    Celis E, Ou D, Otvos L (1988) Recognition of hepatitis B surface antigen by human T lymphocytes. J Immunol 140: 1808–1815PubMedGoogle Scholar
  8. 8.
    Chang LJ, Dienstag J, Ganem D, Varmus H (1989) Detection of antibodies against hepatitis B polymerase antigen in hepatitis B virus-infected patients. Hepatology 10: 332–335PubMedCrossRefGoogle Scholar
  9. 9.
    Ferrari C, Mondelli MU, Penna A, Fiaccadori F, Chisari FV (1987) Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J Immunol 139: 539–544PubMedGoogle Scholar
  10. 10.
    Ferrari C, Penna A, Giuberti T, Tong MJA, Ribera E, Fiaccadori F, Chisari FV (1987) Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol 139: 2050–2058PubMedGoogle Scholar
  11. 11. .
    Ferrari C, Penna A, Bertoletti A, Valli A, Degli Antoni A, Giuberti T, Ca valli A, Petit MA, Fiaccadori F (1990) Cellular immune response to hepatitis B virus (HBV) encoded antigens in acute and chronic HBV infection. J Immunol 145: 3442–3449PubMedGoogle Scholar
  12. 12.
    Feitelson MA, Millman I, Duncan GD, Blumberg BS (1988) Presence of antibodies to the polymerase gene product(s) of hepatitis B and woodchuck hepatitis virus in natural and experimental infections. J Med Virol 24: 121–136PubMedCrossRefGoogle Scholar
  13. 13.
    McChesney MB, Oldstone MBA (1987) Virus perturb lymphocyte functions: selected principles characterizing virus-induced immunosuppression. Ann Rev Immunol 5: 279–304CrossRefGoogle Scholar
  14. 14.
    Milich DR, McLachlan A (1986) The nucleocapsid of hepatitis B virus is both a T-cell-dependent and a T-cell-independent antigen. Science 234: 1398–1401PubMedCrossRefGoogle Scholar
  15. 15.
    Milich DR, McLachlan A, Thornton GB, Hughes JL (1987) Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature 329: 547–549PubMedCrossRefGoogle Scholar
  16. 16.
    Milich DR, Jones JE, Hughes JL, Price J, Raney A, McLachlan A (1990) Is a function of the secreted hepatitis B e antigen to induce immunological tolerance in utero? Proc Natl Acad Sci USA 87: 6657–6661CrossRefGoogle Scholar
  17. 17.
    Mondelli M, Mieli-Vergani G, Alberti A, Vergani D, Portmann B, Eddieston ALWF, Williams R (1982) Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol 129: 2773–2777PubMedGoogle Scholar
  18. 18.
    Moriyama T, Guilhot S, Klopchin K, Moss B, Pinkert CA, Palmiter RD, Brinster RL, Kanagawa O, Chisari FV (1990) Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248: 361–364PubMedCrossRefGoogle Scholar
  19. 19.
    Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M (1990) Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 64: 1298–1303PubMedGoogle Scholar
  20. 20.
    Onji M, Lever AML, Saito I, Thomas HC (1989) Defective response to interferons in cells transfected with the hepatitis B virus genome. Hepatology 9: 92–96PubMedCrossRefGoogle Scholar
  21. 21.
    Penna A, Fowler P, Bertoletti A, Guilhot S, Moss B, Margolskee RF, Cavalli A, Valli A, Fiaccadori F, Chisari FV, Ferrari C (1992) Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTL that recognize endogenously synthesized HBV envelope antigens. J Virol 66: 1193–1198PubMedGoogle Scholar
  22. 22.
    Pignatelli M, Waters J, Lever A, Iwarson S, Gerety R, Thomas H (1987) Cytotoxic T cell response to the nucleocapsid proteins of HBV in chronic hepatitis. J Hepatol 4: 15–21PubMedCrossRefGoogle Scholar
  23. 23.
    Pircher H, Moskophidis D, Rohrer U, Burki K, Hengartner H, Zinkernagel RM (1990) Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346: 629–633PubMedCrossRefGoogle Scholar
  24. 24.
    Schlicht HJ, Shaller H (1989) The secretory core protein of human hepatitis B virus is expressed on the cell surface. J Virol 63: 5399–5404PubMedGoogle Scholar
  25. 25.
    Shirai M, Hanada H, Kurokouchi K, Watanabe S, Nishioka M (1990) Peripheral blood CD4-mediated enhancement and CD8-mediated suppression in the presence of recombinant hepatitis B virus core antigen. J Infect Dis 161: 420–425PubMedCrossRefGoogle Scholar
  26. 26.
    Stemler M, Hess J, Braun R, Will H, Schroder CH (1988) Serological evidence for expression of the polymerase gene of human hepatitis B virus in vivo. J Gen Virol 69: 689–693PubMedCrossRefGoogle Scholar
  27. 27.
    Stemler M, Weimer T, Tu SX, Wan DF, Levrero M, Jung C, Pape GR, Will H (1990) Mapping of B-cell epitopes of the human hepatitis B virus X protein. J Hepatol 64: 2802–2809Google Scholar
  28. 28.
    Stephan W, Prince A, Brotman B (1984) Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen. J Virol 51:420–424PubMedGoogle Scholar
  29. 29.
    Van Den Oord J, de Vos R, Desmet VJ (1986) In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: evidence that HBc-containing hepatocytes may express HLA-DR antigens. Hepatology 6: 981–989PubMedCrossRefGoogle Scholar
  30. 30.
    Vento S, Hegarty JE, Alberti A, O’Brein CJ, Alexander GJM, Eddleston ALWF, Williams R (1985) T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology 5: 192–197PubMedCrossRefGoogle Scholar
  31. 31.
    Weimer T, Weimer K, Tu ZX, Jung C, Pape GR, Will H (1989) Immunogenicity of human hepatitis B virus P-gene derived proteins. J Immunol 143: 3750–3756PubMedGoogle Scholar
  32. 32.
    Yamauchi K, Nakanjshi T, Chiou S, Obata H (1988) Suppression of hepatitis B antibody synthesis by factor made by T cells from chronic hepatitis B carriers. Lancet i: 324–326CrossRefGoogle Scholar
  33. 33.
    Yuki N, Hayashi N, Kasahara A, Katayama K, Ueda K, Fusamoto H, Kamada T (1990) Detection of antibodies against the polymerase gene product in hepatitis B virus infection. Hepatology 12: 193–198PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • C. Ferrari
    • 1
    • 2
  • Amalia Penna
    • 1
  • A. Bertoletti
    • 1
    • 2
  • A. Cavalli
    • 1
  • A. Valli
    • 1
  • G. Missale
    • 1
  • M. Pilli
    • 1
  • S. Marchelli
    • 1
  • T. Giuberti
    • 1
  • F. Fiaccadori
    • 1
  1. 1.Cattedra Malattie InfettiveUniversità di ParmaParmaItaly
  2. 2.Department of Molecular and Experimental MedicineScripps Clinic and Research FoundationLa JollaUSA

Personalised recommendations